6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group studyRavi Bhatia, Mary V. Relling, Jacqueline Casillas et al.|Blood|2014Cited by 204
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic LeukemiaRavi Bhatia, Mary V. Relling, Wendy Landier et al.|JAMA Oncology|2015Cited by 150
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children’s Oncology Group studyWendy Landier, Smita Bhatia, Yanjun Chen et al.|Blood|2017Cited by 46
Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group Study AALL03N1Wendy Landier, Ravi Bhatia, Lindsey Hageman et al.|Journal of Clinical Oncology|2017Cited by 41
High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)Ravi Bhatia, Mary V. Relling, Wendy Landier et al.|Blood|2013Cited by 7